当前位置:首页 > 关于我们 > 创投导师 > 于常海

于常海 | Albert Cheung Hoi Yu


于常海 博士,教授,博士生导师,太平绅士

北京大学教授

香港生物科技协会创始人及主席

粤港澳大湾区生物科技联盟创始人及主席

香港联交所生物技术上市小组委员

亚洲癌症基金会董事

戈登会议董事会成员

海康生命科技有限公司创始人及主席  

 

Albert Cheung Hoi Yu, Professor, PhD, Justice of the Peace (JP)

Professor, Peking University

Founder and President, Hong Kong Biotechnology Organization (HKBIO)

Founder and President, Guangdong-Hong Kong-Macau Great Bay Area Biotechnology Alliance (GBABA)

Biotech Advisory Panel, The Stock Exchange of Hong Kong Limited (HKEX)

Director, Asian Fund for Cancer Research (AFCR)

Board of Trustees, Gordon Research Conference (GRC)  

Founder and Chairman, Hai Kang Life Corporation LimitedHKLife


于常海教授毕业于加拿大萨斯喀彻温大学,取得博士学位,随后在美国加利福尼亚大学旧金山分校、斯坦福大学、香港科技大学和北京大学从事神经科学研究。于教授是世界著名的生物企业家和科学家,在生物领域拥有30余年的经验。已发表科学论文170余篇,在ScienceNature Biotechnology等国际著名期刊上发表多篇评论,出版9本编著;成立HKLife,拥有众多技术发明及世界各国72项专利。创造生物雷达BioRadar®系统,推动精准医学及指导性治疗。他有着广泛的跨文化背景,在学术及商业方面都积极参与。此外,由于拥有全球和在内地扩大关系网络,于教授一直是亚洲生物科技发展对话的重要促进者。最近,他创办和积极推动香港国际生物技术展(BIOHK),为大家在亚洲地区创造一个全球性的生物技术平台,展示创新成果,交流新技术,产品交易,和公司筹集资金等等。 

 

Professor Albert Cheung Hoi Yu received his PhD from the University of Saskatchewan, Canada and spent subsequent years in UCSF, Stanford, HKUST and Peking University. Professor Yu is a world-renowned bio-entrepreneur and scientist with over 30 years of experience in the field of neuroscience and molecular diagnostics. He has published over 170 peer review scientific papers, several commentaries in Science and Nature Biotechnology, and 9 books. He found HKLife and has invented numerous technologies including 72 global patents. Professor Yu creates the BioRadar® system which aims to accelerate the development of precision medicine and guided treatment.  His broad cross-cultural experience and an active involvement in both the academic and business create an extensive global network and contacts in China. He is now an important facilitator of dialogue regarding the development of biotechnology in Asia, putting Hong Kong onto the global biotechnology map.  Recently, he pushes forward a major international biotech convention - BIOHK, so as for all of us to have a global biotech platform in Asia to showcase our accomplishments, exchange ideas, trade our products, fundraising, and more.


0.177627s